Speakers - Sachs Associates
Speakers - Sachs Associates
Speakers - Sachs Associates
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
CONTACTS<br />
Dr Christof Böhler<br />
Chief Business Officer<br />
DDr Sven Rohmann<br />
Chief Business Officer<br />
ADDRESS<br />
Industriering 21<br />
9494 Ruggell<br />
Liechtenstein<br />
TELEPHONE<br />
+423 377 78 00<br />
FAX<br />
+423 377 78 99<br />
EMAIL<br />
info@pantec-biosolutions.com<br />
YEAR FOUNDED<br />
2005<br />
Pantec Biosolutions AG<br />
www.pantec-biosolutions.com<br />
FINANCIAL SUMMARY<br />
Pantec is funded by private investors and one VC company.<br />
The company is seeking new investors alongside existing shareholders in a new financing round.<br />
COMPANY PROFILE<br />
Pantec Biosolutions is the leading company for stable and controlled dermal delivery of large weight<br />
biopharmaceuticals. Our goal is to replace injection based medication of biologicals in selected disease areas<br />
with the help of a breakthrough dermal delivery method. The proprietary combination of P.L.E.A.S.E.® (Precise<br />
Laser Epidermal System) microporation technology with intradermal drug delivery allows easy to use, safe,<br />
rapid and painless application of infertility hormones and other large molecular weight biopharmaceuticals. This<br />
platform significantly improves precise drug uptake in addition to reducing treatment duration and avoiding the<br />
need for injections. This technology has significant potential to unlock a high unmet need of treatments requiring<br />
large molecular weight biopharmaceuticals.<br />
The company’s focus is in combining laser of laser microporation with drug delivery in the dermatology and<br />
immunology space.<br />
In addition P.L.E.A.S.E.® can also be used “stand alone” as a new category fractional ablative laser device to<br />
break new ground in aesthetic dermatology.<br />
MANAGEMENT<br />
Dr Boehler Christof, CEO<br />
Mr Bragagna Thomas, CTO<br />
Dr Dr med. Rohmann Sven, CBO<br />
Dr. Clemens Norbert, Clinical Director as permanent consultant<br />
Dr Kalia Yogeshvar N, Chief Scientific Advisor<br />
t back :: next u<br />
WELCOME PHARMA LICENSING GROUPS<br />
SPEAKERS<br />
PRESENTING COMPANIES SUPPORTING ORGANISATIONS<br />
ORGANISERS